12:00 AM
 | 
Mar 11, 2013
 |  BioCentury  |  Finance

Advent warms CoCo

Alzheimer's paly CoCo Therapeutics emerges out of Wellcome seed funding
Advent warms CoCo

On the heels of data published last month from the lab of Jonathan Corcoran, Advent Venture Partners launched CoCo Therapeutics Ltd. to develop his retinoic acid receptor alpha (RARA) agonists to treat Alzheimer's disease.

Corcoran is director of...

Read the full 188 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >